Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-02

Clinical Trial Update: Inuline Supplement in Patients With Irritable Bowel Syndrome [NA]

View source ↗

Summary

This document notes a clinical trial evaluating an inulin supplement for Irritable Bowel Syndrome, with the study status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inuline supplement (inulin)

Snippet

Sponsor: SC Fiterman Pharma SRL | Conditions: Irritable Bowel Syndrome | NA | Status: UNKNOWN